These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9230825)

  • 1. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes.
    Lindén C; Alm A
    Arch Ophthalmol; 1997 Jul; 115(7):857-61. PubMed ID: 9230825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latanoprost and physostigmine in human eyes.
    Cox TA
    Arch Ophthalmol; 1998 Mar; 116(3):398-9. PubMed ID: 9514504
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow.
    Vanlandigham BD; Brubaker RF
    Am J Ophthalmol; 1998 Aug; 126(2):191-6. PubMed ID: 9727512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
    Serle JB; Podos SM; Kitazawa Y; Wang RF
    Jpn J Ophthalmol; 1998; 42(2):95-100. PubMed ID: 9587840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes.
    Serle JB; Wang RF; Mittag TW; Shen F; Podos SM
    J Glaucoma; 2001 Jun; 10(3):215-9. PubMed ID: 11442186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine increases aqueous humor production in human eyes.
    Lindén C; Alm A
    Curr Eye Res; 1997 Nov; 16(11):1166-70. PubMed ID: 9395778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanism for the additivity of pilocarpine and latanoprost.
    Toris CB; Zhan GL; Zhao J; Camras CB; Yablonski ME
    Am J Ophthalmol; 2001 Jun; 131(6):722-8. PubMed ID: 11384567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
    Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
    Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and cholinomimetics.
    Kaufman PL
    Arch Ophthalmol; 1997 Jul; 115(7):911-3. PubMed ID: 9230833
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
    Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
    J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes.
    Geyer O; Man O; Weintraub M; Silver DM
    Am J Ophthalmol; 2001 Feb; 131(2):198-202. PubMed ID: 11228295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.
    Sponsel WE; Mensah J; Kiel JW; Remky A; Trigo Y; Baca W; Friberg T
    Am J Ophthalmol; 2000 Aug; 130(2):151-9. PubMed ID: 11004288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
    Ziai N; Dolan JW; Kacere RD; Brubaker RF
    Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
    Toris CB; Camras CB; Yablonski ME
    Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study.
    Rácz P; Ruzsonyi MR; Nagy ZT; Bito LZ
    Arch Ophthalmol; 1993 May; 111(5):657-61. PubMed ID: 8489449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.